Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $3.11 and traded as high as $3.15. Hypera shares last traded at $3.15, with a volume of 1,217 shares traded.
Hypera Price Performance
The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.41 and a current ratio of 1.81. The business’s 50-day moving average is $3.11 and its 200-day moving average is $4.29.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- 3 Warren Buffett Stocks to Buy Now
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Buy Cheap Stocks Step by Step
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.